Cannabics Pharmaceuticals Inc. Contracts & Agreements
53 Contracts & Agreements
- Business Finance (25 contracts)
- Business Operations (3)
- Human Resources (7)
- Intellectual Property (3)
- Mergers & Acquisitions (1)
- Uncategorized (14)
- Form of Forbearance Agreement (Filed With SEC on March 16, 2022)
- Form of Demand Promissory Note (Filed With SEC on March 16, 2022)
- Employment Agreement between Gabriel Yariv and Grin Ultra Ltd., dated November 11, 2021 (Filed With SEC on February 18, 2022)
- Equity Incentive Plan (Filed With SEC on February 18, 2022)
- Form of Forbearance Agreement (Filed With SEC on February 17, 2022)
- Board of Directors Resolution Appointing Gabriel Yariv as Chair (Filed With SEC on September 13, 2021)
- Board of Directors Resolution Appointing Dr. Gil Feiler as Independent Board Member (Filed With SEC on July 19, 2021)
- Form of Senior Secured Convertible Note of April 23, 2021 (Filed With SEC on April 28, 2021)
- Amended and Restated Securities Purchase Agreement as of February 22, 2021 (Filed With SEC on April 28, 2021)
- Form of Senior Convertible Note of February 22, 2021 (Filed With SEC on April 28, 2021)
- Amended and Restated Securities Purchase Agreement (Filed With SEC on February 23, 2021)
- Employment Agreement between Eyal Barad and the Company, dated June 10, 2018 (Filed With SEC on January 27, 2021)
- Employment Agreement between Eyal Ballan and the Company, dated June 10, 2018 (Filed With SEC on January 27, 2021)
- Amended Employment Agreement between Gabriel Yariv and Grin Ultra Ltd., dated September 10, 2020 (Filed With SEC on January 27, 2021)
- Consulting Agreement between CFO Direct and Grin Ultra Ltd., dated November 1, 2016 (Filed With SEC on January 27, 2021)
- Form of Securities Purchase Agreement (Filed With SEC on December 21, 2020)
- Form of Senior Secured Convertible Note (Filed With SEC on December 21, 2020)
- Form of Warrant (Filed With SEC on December 21, 2020)
- Form of Registration Rights Agreement (Filed With SEC on December 21, 2020)
- Form of Security and Pledge Agreement (Filed With SEC on December 21, 2020)
- Form of Guaranty (Filed With SEC on December 21, 2020)
- Service Agreement (Filed With SEC on November 16, 2020)
- Board of Directors Resolution Dismissing Itamar Borochov (Filed With SEC on September 2, 2020)
- Shareholders Resolution Dismissing Itamar Borochov (Filed With SEC on September 2, 2020)
- Board of Directors Resolution Appointing Itamar Borochov as Chairman of the Board (Filed With SEC on April 17, 2020)
- Board of Directors Resolution Appointing Gabriel Yariv as President of the Company (Filed With SEC on April 17, 2020)
- Letter of Resignation of Ehud Reiger (Filed With SEC on October 11, 2019)
- Letter of Resignation of Eyal Ballan (Filed With SEC on October 11, 2019)
- Shareholders Resolution removing Estery Giloz-Ran and Eran Ballan as Directors and Board Members and Appointing Gabriel Yariv as Director and Board Member (Filed With SEC on October 7, 2019)
- Shareholders Resolution Appointing Itamar Borochov as Director (Filed With SEC on October 3, 2019)
- Board of Directors Resolution Appointing Independent Directors (Filed With SEC on June 25, 2019)
- Joint Venture Agreement by and between Cannabics Pharmaceuticals Inc. and Wize Pharma, Inc., dated February 7, 2019 (Filed With SEC on February 13, 2019)
- Form of Warrant (Filed With SEC on September 27, 2018)
- Form of Placement Agent Warrant (Filed With SEC on September 27, 2018)
- Form of Securities Purchase Agreement (Filed With SEC on September 27, 2018)
- Placement Agent Agreement (Filed With SEC on September 27, 2018)
- Convertible Loan Agreement (Filed With SEC on August 14, 2018)
- SEDA Agreement, dated as of May 8, 2018, between Cannabics Pharmaceuticals Inc. and YAII PN Ltd (Filed With SEC on May 2, 2018)
- Shareholders Resolution (Filed With SEC on January 30, 2018)
- Resolution of the Board of Directors regarding resignation of Itamar Borochov (Filed With SEC on January 30, 2018)
- Shareholders Resolution (Filed With SEC on November 13, 2017)
- SECURITIESPURCHASE AGREEMENT (Filed With SEC on May 10, 2017)
- IP LICENSE AGREEMENT (Filed With SEC on January 29, 2016)
- IP LICENSE AGREEMENT (Filed With SEC on January 29, 2016)
- CANNABICS PHARMACEUTICALS INC. CONSULTING AGREEMENT (Filed With SEC on April 9, 2015)
- RESOLUTION OF THE SHAREHOLDERS OF CANNABICS PHARMACEUTICALS INC. (Filed With SEC on January 23, 2015)
- LICENSE AGREEMENT (Filed With SEC on January 6, 2015)
- IP LICENSE AND COLLABORATION AGREEMENT (Filed With SEC on November 5, 2014)
- COLLABORATION & EXCLUSIVITYAGREEMENT (Filed With SEC on July 25, 2014)
- DEBT RESTRUCTURING AGREEMENT (Filed With SEC on October 29, 2013)
- CONVERTIBLE PROMISSORY NOTE (Filed With SEC on October 29, 2013)
- Promissory Note (Filed With SEC on July 2, 2013)
- Mutual Rescission Agreement (Filed With SEC on November 14, 2011)
